CDER Shifts Dispute Resolution Program Due to Spike in Generic Appeals

By Sam | June 11, 2018

An increased number of generic appeals has led CDER to transfer the management of its Formal Dispute Resolution program for sponsors of user fee products from the Office of New Drugs to the Office of Executive Programs, CDER Director Janet Woodcock said in a staff memo.
Source: Drug Industry Daily

Posted in Drug Industry Daily